Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 3, 2005, Pages 227-235

  Christiansen, Lene ^a,b   Brons Poulsen J ^a,c   Horder M ^a   Brock, A ^d   Petersen, N E ^a,e  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AGILENT TECHNOLOGIES   (United States)

^d VIBORG HOSPITAL   (Denmark)

^e SVENDBORG HOSPITAL   (Denmark)

Author keywords

Mutations; Porphyria cutanea tarda; Residual activity; Uroporphyrinogen decarboxylase

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MUTANT PROTEIN; PORPHYRIN; RECOMBINANT PROTEIN; UROPORPHYRINOGEN DECARBOXYLASE;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; GENE MUTATION; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS;

GENE EXPRESSION; HUMANS; KINETICS; MUTATION; RECOMBINANT PROTEINS; UROPORPHYRINOGEN DECARBOXYLASE;

PROKARYOTA;

EID: 18844454510     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510510013631     Document Type: Article

References (29)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill; 1995. pp 2103-60.
2. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998;18:67-75.
3. Mascaro JM. The porphyrias: a brief overview based on 25 years of experience (1969-1994) by the Department of Dermatology of the Hospital Clinic and Faculty of Medicine of Barcelona, Spain. J Dermatol 1995;22:823-8.
4. Bygum A, Chrisnansen L, Petersen NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003;83:115-20.
5. Cruz-Rojo J, Fontanellas A, Moran-Jimenez MJ, Navarro-Ordonez S, Garcia-Bravo M, Mendez M, et al. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol 2002;48:845-52.
6. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda [see comments]. Lancet 1997;349(9048):321-3.
7. Lamoril J, Andant C, Gouya L, Malonova E, Grandchamp B, Martasek P, et al. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT). Cell Mol Biol 2002;48:33-41.
8. Romana M, Dubart A, Beaupain D, Chabret C, Goossens M, Romeo PH. Structure of the gene for human uroporphyrinogen decarboxylase. Nucleic Acids Res 1987;15:7343-56.
9. Moran-Jimenez MJ, Ged C, Romana M, Enriquez DS, Taieb A, Topi G, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet 1996;58:712-21.
10. Christiansen L, Ged C, Hombrados I, Brons-Poulsen J, Fontanellas A, de Verneuil H, et al. Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT. Hum Mutat 1999;14:222-32.
11. Phillips JD, Parker TL, Schubert HL, Whitby FG, Hill CP, Kushner JP. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase. Blood 2001;98:3179-85.
12. Cappellini MD, Martinez DM, Tavazzi D, Fargion S, Pizzuti A, Comino A, et al. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT). Hum Mutat 2001;17:350.
13. Garey JR, Harrison LM, Franklin KF, Metcalf KM, Radisky ES, Kushner JP. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest 1990;86:1416-22.
14. McManus JF, Begley CG, Sassa S, Ratnaike S. Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria. Blood 1996;88:3589-600.
15. Meguro K, Fujita H, Ishida N, Akagi R, Kurihara T, Galbraith RA, et al. Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Invest Dermatol 1994;102:681-5.
16. Phillips JD, Whitby FG, Kushner JP, Hill CP. Characterization and crystallization of human uroporphyrinogen decarboxylase. Protein Sci 1997;6:1343-6.
17. Whitby FG, Phillips JD, Kushner JP, Hill CP. Crystal structure of human uroporphyrinogen decarboxylase. EMBO J 1998;17:2463-71.
18. Christiansen L, Bygum A, Jensen A, Brandrup F, Thomsen K, Horder M, et al. Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda. Scand J Clin Lab Invest 2000;60:611-5.
19. Brøns-Poulsen J, Petersen NE, Hørder M, Kristiansen K. An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes 1998;12:345-8.
20. Marczinovits I, Somogyi C, Patthy A, Nemeth P, Molnar J. An alternative purification protocol for producing hepatitis B virus X antigen on a preparative scale in Escherichia coli. J Biotechnol 1997;56:81-8.
21. Wan M, Takagi M, Loh BN, Imanaka T. Comparison of HIV-1 protease expression in different fusion forms. Biochem Mol Biol Int 1995;36:411-9.
22. de Carlos A, Montenegro D, Alonso-Rodriguez A, Paez dlC, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Purification of human alpha-L-fucosidase precursor expressed in Escherichia coli as a glutathione S-transferase fusion protein. J Chromatogr B Analyt Technol Biomed Life Sci 2003;786:7-15.
23. de Verneuil H, Sassa S, Kappas A. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem 1983;258:2454-60.
24. Sassa S, de Verneuil H, Anderson KE, Kappas A. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda. Trans Assoc Am Phys 1983;96:65-75.
25. Roberts AG, Elder GH. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. Methods Enzymol 1997;281:349-55.
26. de Verneuil H, Grandchamp B, Nordmann Y. Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochim Biophys Acta 1980;611:174-86.
27. Mukerji SK, Pimstone NR. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda. Biochem Biophys Res Commun 1985;127:517-25.
28. Wyckoff EE, Phillips JD, Sowa AM, Franklin MR, Kushner JP. Mutational analysis of human uroporphyrinogen decarboxylase. Biochim Biophys Acta 1996;1298:294-304.
29. Wagner E, Lykke-Andersen J. mRNA surveillance: the perfect persist. J Cell Sci 2002;115:3033-8.